AstraZeneca
PLC (NYSE: AZN) entered an agreement to develop Inovio Pharmaceuticals Inc.'s
(Nasdaq: INO) experimental cancer vaccine INO-3112. Shares of Inovio soared $1.63 to $8.12 while AstraZeneca stock rose 36 cents to $34.05.
Inovio partners with AstraZeneca
August 10, 2015 at 12:53 PM EDT
